NCT06405685 2024-05-08
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
Clinical Trials
11 trialsNCT03766178 2021-07-07
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT03400592 2018-01-17
NIEGA
Peking University
Phase 2 Unknown
NCT02945267 2016-10-26
Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer
Chinese PLA General Hospital
Phase 4 Unknown
NCT01993784 2013-11-25
Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.
Peking University
Phase 1/2 Unknown
NCT01180166 2013-09-19
Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT01899118 2013-07-15
Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT01402180 2011-07-26
Nimotuzumab
Fudan University
Phase 2/3 Unknown
NCT01336049 2011-04-15
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer
Peking University
Phase 2 Unknown
NCT00972465 2009-09-07
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
Phase 2 Unknown